ClinicalTrials.gov
ClinicalTrials.gov Menu

Improved Use of Antibiotic Guidelines in Hospital Environment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00512772
Recruitment Status : Completed
First Posted : August 8, 2007
Last Update Posted : December 20, 2010
Sponsor:
Information provided by:
Katholieke Universiteit Leuven

Brief Summary:
The purpose of this study is to determine if the use of antibiotic guidelines and thus antibiotics can be improved through a description of possible barriers leading to tailored interventions.

Condition or disease
Community-Acquired Pneumonia

Study Type : Observational
Actual Enrollment : 823 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Improved Use of Antibiotic Guidelines in in Hospital Environment: Research on an Implementation Model and the Role of the Hospital Pharmacist.
Study Start Date : October 2007
Actual Primary Completion Date : July 2010
Actual Study Completion Date : July 2010

Resource links provided by the National Library of Medicine






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients admitted to the hospital with a diagnosis of community-acquired pneumonia or community-acquired pyelonephritis
Criteria

Inclusion Criteria:

  • Diagnosed community-acquired pneumonia (CAP)
  • Diagnosed community-acquired pyelonephritis

Exclusion Criteria:

  • CAP: hospital-acquired pneumonia; patients transferred from other hospital; death within 24h, aspiration pneumonia, immunocompromised status, palliative status, admission due to social reasons
  • Pyelonephritis: urinary tract with functional or physical abnormalities, urinary catheterisation, pregnancy, (immunocompromised status, palliative status, admission due to social reasons and history of renal transplant.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00512772


Locations
Belgium
Ziekenhuis Oost-Limburg
Genk, Belgium, 3600
Universitair Ziekenhuis Gasthuisberg
Leuven, Belgium, 3000
Sponsors and Collaborators
Katholieke Universiteit Leuven
Investigators
Principal Investigator: Pieter-Jan Cortoos, PharmD Katholieke Universiteit Leuven
Study Director: Gert Laekeman, PhD Katholieke Universiteit Leuven

Responsible Party: Pieter-Jan Cortoos, PharmD, Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier: NCT00512772     History of Changes
Other Study ID Numbers: B32220072383
First Posted: August 8, 2007    Key Record Dates
Last Update Posted: December 20, 2010
Last Verified: July 2010

Keywords provided by Katholieke Universiteit Leuven:
Time series
Implementation

Additional relevant MeSH terms:
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Anti-Bacterial Agents
Anti-Infective Agents